Pacific Biosciences of California, Inc. Finance Lease, Right-of-Use Asset, Amortization
Pacific Biosciences of California, Inc. (PACB) reported Finance Lease, Right-of-Use Asset, Amortization of $6.81 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2024-02-28
- Pacific Biosciences of California, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-12-31 was $1.77M, a 10.67% increase year-over-year.
- Pacific Biosciences of California, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-09-30 was $1.74M, a 114.29% increase year-over-year.
- Pacific Biosciences of California, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-06-30 was $1.72M, a 114.23% increase year-over-year.
- Pacific Biosciences of California, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2022-03-31 was $1.70M, a 114.68% increase year-over-year.
- Pacific Biosciences of California, Inc. finance lease, right-of-use asset, amortization for fiscal 2023 was $6.81M, a 1.66% decline from fiscal 2022.
- Pacific Biosciences of California, Inc. finance lease, right-of-use asset, amortization for fiscal 2022 was $6.92M, a 72.91% increase from fiscal 2021.
- Pacific Biosciences of California, Inc. finance lease, right-of-use asset, amortization for fiscal 2021 was $4.00M, a 39.26% increase from fiscal 2020.
- Pacific Biosciences of California, Inc. finance lease, right-of-use asset, amortization for fiscal 2020 was $2.88M, a 7.19% increase from fiscal 2019.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2023-12-31 | $6.81M 10-K · filed 2024-02-28 | |||
| 2022-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.51M derived: sum of 2 quarters · filed 2024-02-28 | $5.23M derived: sum of 3 quarters · filed 2024-02-28 | $6.92M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $3.46M derived: sum of 2 quarters · filed 2022-11-08 | $5.15M 10-Q · filed 2022-11-08 | $6.75M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.41M 10-Q · filed 2022-08-08 | $5.01M derived: sum of 3 quarters · filed 2024-02-28 | $5.83M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $1.70M 10-Q · filed 2022-05-06 | $3.30M derived: sum of 2 quarters · filed 2024-02-28 | $4.11M derived: sum of 3 quarters · filed 2024-02-28 | $4.91M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.41M derived: sum of 2 quarters · filed 2024-02-28 | $3.21M derived: sum of 3 quarters · filed 2024-02-28 | $4.00M 10-K · filed 2024-02-28 |
| 2021-09-30 | $812.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $1.61M derived: sum of 2 quarters · filed 2022-11-08 | $2.40M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $801.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.59M 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | $790.00K 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $2.88M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $2.68M 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |